A detailed history of Black Rock Inc. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,741,923 shares of RYTM stock, worth $377 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,741,923
Previous 6,529,646 3.25%
Holding current value
$377 Million
Previous $283 Million 2.16%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$35.41 - $44.37 $7.52 Million - $9.42 Million
212,277 Added 3.25%
6,741,923 $277 Million
Q1 2024

May 10, 2024

BUY
$39.12 - $52.44 $6.96 Million - $9.33 Million
177,896 Added 2.8%
6,529,646 $283 Million
Q4 2023

Feb 13, 2024

BUY
$21.39 - $49.64 $3.25 Million - $7.54 Million
151,868 Added 2.45%
6,351,750 $292 Million
Q3 2023

Nov 13, 2023

SELL
$15.81 - $27.8 $1.03 Million - $1.81 Million
-65,123 Reduced 1.04%
6,199,882 $142 Million
Q2 2023

Aug 11, 2023

BUY
$16.32 - $21.15 $40.5 Million - $52.5 Million
2,484,406 Added 65.71%
6,265,005 $103 Million
Q1 2023

May 12, 2023

BUY
$16.88 - $34.24 $960,218 - $1.95 Million
56,885 Added 1.53%
3,780,599 $67.4 Million
Q4 2022

Feb 13, 2023

BUY
$22.21 - $30.25 $4.14 Million - $5.63 Million
186,215 Added 5.26%
3,723,714 $108 Million
Q3 2022

Nov 14, 2022

BUY
$4.3 - $30.85 $10.1 Million - $72.8 Million
2,359,924 Added 200.41%
3,537,499 $86.7 Million
Q2 2022

Aug 12, 2022

SELL
$3.12 - $12.25 $6.57 Million - $25.8 Million
-2,106,530 Reduced 64.14%
1,177,575 $4.89 Million
Q1 2022

May 12, 2022

SELL
$6.13 - $12.24 $269,450 - $538,021
-43,956 Reduced 1.32%
3,284,105 $37.8 Million
Q4 2021

Feb 10, 2022

SELL
$8.62 - $13.9 $292,433 - $471,557
-33,925 Reduced 1.01%
3,328,061 $33.2 Million
Q3 2021

Nov 09, 2021

BUY
$11.68 - $20.72 $307,476 - $545,454
26,325 Added 0.79%
3,361,986 $43.9 Million
Q2 2021

Aug 11, 2021

BUY
$18.52 - $22.55 $61.8 Million - $75.2 Million
3,335,661 New
3,335,661 $65.3 Million

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.11B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.